Novo Nordisk Settles Patent Dispute With Pfizer

Law360, New York (December 11, 2007, 12:00 AM EST) -- Pharmaceutical company Novo Nordisk Inc. has reached a settlement in a patent dispute with rival drug maker Pfizer Inc. over the diabetes treatment Exubera, the company said in a statement released late Monday.

The inhaled insulin treatment was at the center of the lawsuit filed by Novo Nordisk in August 2006 in the U.S. District Court for the Southern District of New York alleging Pfizer willfully infringed five of its patents related to the drug.

A spokesperson for Novo Nordisk said the company did have immediate...
To view the full article, register now.